Prevalence and risk factors of COPD in some areas of Shaanxi Province

HU Zhi-ping; WANG Yan-ping; LI Ya-jun; QIU Lin; LIU Rong; WANG Wei-hua; WU Meng; SA Ri-na

doi:10.16462/j.cnki.zhjbkz.2020.10.024

Volume 24 Issue 10

Nov. 2020

Turn off MathJax

Article Contents

Article Navigation > CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION > 2020 > 24(10): 1233-1236

HU Zhi-ping, WANG Yan-ping, LI Ya-jun, QIU Lin, LIU Rong, WANG Wei-hua, WU Meng, SA Ri-na. Prevalence and risk factors of COPD in some areas of Shaanxi Province[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2020, 24(10): 1233-1236. doi: 10.16462/j.cnki.zhjbkz.2020.10.024

Citation:

HU Zhi-ping, WANG Yan-ping, LI Ya-jun, QIU Lin, LIU Rong, WANG Wei-hua, WU Meng, SA Ri-na. Prevalence and risk factors of COPD in some areas of Shaanxi Province[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2020, 24(10): 1233-1236. doi: 10.16462/j.cnki.zhjbkz.2020.10.024

Citation:

PDF( 872 KB)

Prevalence and risk factors of COPD in some areas of Shaanxi Province

doi: 10.16462/j.cnki.zhjbkz.2020.10.024

Chronic Diease Center Shaanxi Center for Disease Control and Prevention, Xi'an 710054, China

Funds:

The Central Government Transferred Funds to Pay For Major Local Public Health Projects 2014

More Information

Corresponding author: SA Ri-na E-mail:38219471@qq.com
Received Date: 2020-01-06
Rev Recd Date: 2020-04-19
Publish Date: 2020-10-10

Abstract

Abstract

Objective To investigate the prevalence and influencing factors of chronic obstructive pulmonary disease (COPD) in people aged 40 and above in some areas of Shaanxi Province. Methods The multi-stage stratified cluster random sampling method was used in this study. A total of 1 800 residents aged 40 and above were selected from three monitoring districts in Shaanxi.Interview survey, physical measurement and pulmonary function were examined. The relevant factors were analyzed by test and binary logistic regression analysis. Results A total of 1 638 effective samples were obtained. The prevalence of COPD was 13.8%. Prevalence rate in male (18.5%) was higher than that in female (9.6%)(χ²=27.399, P < 0.001); the prevalence of the age group of 70 years and above (22.5%) was the highest. The prevalence of COPD was 20.4%, 12.9% and 8.5% in 60-, 50- and 40- group respectively. With aging, the prevalence was increasing(χ_trend²=31.970, P < 0.001). Multivariate logistic regression analysis showed that the risk factors for COPD were age (OR=2.86, 95% CI:1.52-5.39, P=0.001), smoke (OR=1.60, 95% CI:1.12-2.27, P=0.031) and family history of respiratory diseases (OR=1.83, 95% CI:1.05-3.18, P=0.008). Conclusions The prevalence of COPD is high in some areas of Shaanxi Province. The risk factors for COPD are old age, smoking and family history of respiratory diseases.
- Chronic obstructive pulmonary disease,
- Epidemic situation,
- Risk factors

FullText(HTML)

References(11)

References

[1]	Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010:systematic analysis for the Global Burden of Disease Study 2010[J]. Lancet, 2012, 380(9859):2095-2128.
[2]	国家卫生计生委疾病预防控制局.中国居民营养与慢性病状况报告(2015年)[M].北京:人民卫生出版社, 2015. The national health and family planning commission of the people's republic of China for bureau of disease prevention and control. Nutrition and chronic diseases in Chinese Residents (2015)[M]. Beijing:People's Medical Publishing House, 2015.
[3]	中国疾病预防控制中心慢性非传染性疾病预防控制中心.中国死因监测数据集(2015)[M].北京:中国科学技术出版社, 2016. The national center for chronic and noncommunicable disease control and prevention. Death cause monitoring data set in China (2015)[M]. Beijing:Science and technology of China press, 2016.
[4]	方利文, 包鹤龄, 王宝华, 等.中国居民慢性阻塞性肺疾病监测内容与方法概述[J].中华流行病学杂志, 2018, 39(5):546-550. DOI: 10.3760/cma.j.issn.0254-6450.2018.05.002. Fang LW, Bao HL, Wang BH, et al. A summary of item and method of national chronic obstructive pulmonary disease surveillance in China[J]. Chin J Epidemiol, 2018, 39(5):546-550. DOI: 10.3760/cma.j.issn.0254-6450.2018.05.002.
[5]	中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南(2013年修订版)[J].中国医学前沿杂志(电子版), 2014, 6(2):67-80. Chronic obstructive pulmonary disease group, respiratory branch, Chinese medical association. Guidelines for diagnosis and treatment of chronic obstructive pulmonary disease (2013 Revision)[J]. Chin J Front Med Sci (Electronic Version), 2014, 6(2):67-80.
[6]	Fang LW, Gao P, Bao HL, et al. Chronic obstructive pulmonary disease in China:a nationwide prevalence study[J]. Lancet Respir Med, 2018, 6(6):421-430.
[7]	唐雨萌, 李茜, 张岚, 等.湖北省慢性阻塞性肺疾病流行病学调查及影响因素[J].中华疾病控制杂志, 2018, 22(7):721-725. DOI: 10.16462/j.cnki.zhjbkz.2018.07.016. Tang YM, Li Q, Zhang L, et al. An epidemiological survey and risk factors analysis of chronic obstructive pulmonary disease in Hubei Province[J]. Chin J Dis Control Prev, 2018, 22(7):721-725. DOI: 10.16462/j.cnki.zhjbkz.2018.07.016.
[8]	张银娥, 吴婷婷, 马丽霞, 等.宁夏监测点居民慢性阻塞性肺疾病流行特征及危险因素调查分析[J].中华疾病控制杂志, 2018, 22(3):231-234. DOI: 10.16462/j.cnki.zhjbkz.2018.03.005. Zhang YE, Wu TT, Ma LX, et al. Investigation of the epidemic characteristics and risk factor for chronic obstructive pulmonary disease among residents from monitoring point in Ningxia[J]. Chin J Dis Control Prev, 2018, 22(3):231-234. DOI: 10.16462/j.cnki.zhjbkz.2018.03.005.
[9]	潘东霞, 钱一建, 王春梅, 等.吸烟与室内空气污染的交互作用对慢性阻塞性肺部疾病影响的分析[J].中华流行病学杂志, 2016, 37(11):1444-1449. DOI: 10.3760/cma.j.issn.0254-6450.2016.11.002. Pan DX, Qian YJ, Wang CM, et al. Interaction between smoking and indoor air pollution on chronic obstructive pulmonary diseases[J]. Chin J Epidemiol, 2016, 37(11):1444-1449. DOI: 10.3760/cma.j.issn.
[10]	Hoffmann RF, Zarrintan S, Brandenburg SM, et al. Prolonged cigarette smoke exposure alters mitochondrial structure and function in airway epithelial cells[J]. Respir Res, 2013, 14(1):97-106.
[11]	胡大鹏, 鲍文华, 孙云晖, 等.慢性阻塞性肺疾病易感基因研究进展[J].中国老年保健医学, 2016, 14(6):3-6. DOI: 10.3969/j.issn.1672-4860.2016.06.001. Hu DP, Bao WH, Sun YH, et al. A review on suspected chronic obstructive pulmonary disease genes[J]. Chinese Journal of Geriatric Care, 2016, 14(6):3-6. DOI: 10.3969/j.issn.1672-4860.2016.06.001.